4006-776-356 出国就医服务电话

免费获得国外相关药品,最快 1 个工作日回馈药物信息

出境医 / 临床实验 / Prognostic Potential of Preoperative Nutritional Status and Postoperative Change in Patients Undergoing Hip Arthroplasty (NUTRIANCA)

Prognostic Potential of Preoperative Nutritional Status and Postoperative Change in Patients Undergoing Hip Arthroplasty (NUTRIANCA)

Study Description
Brief Summary:
Data literature lacks of evidence concerning the variation of the nutritional status in patients undergoing hip surgery, thus preventing an effective application a nutritional support program. It is therefore necessary to start identifying the clinical steps (pre-operative and post-operative) that may be defined as critical control points for malnutrition. The observation should foresee the identification of nutritional status indicators, such as weight, hemoglobin, albumin, food intake, and others that might affect a proper recovery. This study aims to investigate the prognostic nutritional factors that might influence clinical outcomes, and their variation in relation to hospitalization and rehabilitation periods.

Condition or disease
Hip Arthropathy Malnutrition; Anemia Frail Elderly Syndrome

Detailed Description:
Data literature lacks of evidence concerning the variation of the nutritional status in patients undergoing hip surgery, thus preventing an effective application a nutritional support program. It is therefore necessary to start identifying the clinical steps (pre-operative and post-operative) that may be defined as critical control points for malnutrition. Patients undergoing hip surgery would be enrolled before the surgical operation and would be evaluated three times: preoperative, postoperative, and after discharge. The observation should foresee the identification of nutritional status indicators, such as weight, hemoglobin, albumin, food intake, and others that might affect a proper recovery. This study aims to investigate the prognostic nutritional factors that might influence clinical outcomes, and their variation in relation to hospitalization and rehabilitation periods.
Study Design
Layout table for study information
Study Type : Observational
Estimated Enrollment : 60 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Prognostic Potential of the Preoperative Nutritional Status and Its Postoperative Variation in Patients Undergoing Hip Arthroplasty
Actual Study Start Date : May 31, 2019
Estimated Primary Completion Date : April 2021
Estimated Study Completion Date : April 2022
Arms and Interventions
Outcome Measures
Primary Outcome Measures :
  1. Change from baseline level of hemoglobin at 14 days after surgical operation [ Time Frame: Before the surgical operation, after 3 days, after 14 days. ]
    One of the main decision-making factors that guide the clinician to discharge the patient is the hemoglobin level. The association between preoperative hemoglobin and hemoglobin at discharge was already observed in past orthopedic cohorts, with a loss of 3.3 g/dl being considered clinically relevant. Patients with a better nutritional status may have a reduced fall in hemoglobin after the surgical operation.


Secondary Outcome Measures :
  1. Change from baseline level of pre-albumin at 14 days after surgical operation [ Time Frame: Before the surgical operation, after 3 days, after 14 days. ]
    Pre-albumin (mg/dl)

  2. Change from baseline level of total lymphocyte count at 14 days after surgical operation [ Time Frame: Before the surgical operation, after 3 days, after 14 days. ]
    Total lymphocyte count (cells/mm^3)

  3. Change from baseline level of iron at 14 days after surgical operation [ Time Frame: Before the surgical operation, after 3 days, after 14 days. ]
    Iron (μg/dl)

  4. Change from baseline level of vitamin D at 14 days after surgical operation [ Time Frame: Before the surgical operation, after 3 days, after 14 days. ]
    25[OH]D (ng/ml)

  5. Change from baseline of weight 14 days after surgical operation [ Time Frame: Before the surgical operation, after 3 days, after 14 days. ]
    Weight (kg)

  6. Change from baseline of calf circumference 14 days after surgical operation [ Time Frame: Before the surgical operation, after 3 days, after 14 days. ]
    Calf circumference (cm)

  7. Change from baseline of % of fat mass at 14 days after surgical operation [ Time Frame: Before the surgical operation, after 3 days, after 14 days. ]
    Bioelectrical impedance analysis (% of fat mass and % of lean mass)

  8. Change from baseline of hand-grip strength at 14 days after surgical operation [ Time Frame: Before the surgical operation, after 3 days, after 14 days. ]
    Hand-grip strength (kg). For this test, the higher values, the better is.

  9. Change from baseline of FIM test at 14 days after surgical operation [ Time Frame: Before the surgical operation, after 3 days, after 14 days. ]
    Functional Independence Measure (FIM) (18-126 point scale). For this test, the higher values, the better is.

  10. Change from baseline of 10 meter walking test at 14 days after surgical operation [ Time Frame: Before the surgical operation, after 3 days, after 14 days. ]
    10 meter walking test (m/s). For this test, the higher values, the better is.

  11. Change from baseline of POMA at 14 days after surgical operation [ Time Frame: Before the surgical operation, after 3 days, after 14 days. ]
    Performance Oriented Mobility Assessment (POMA) (0-32 point scale). For this test, the higher values, the better is.


Eligibility Criteria
Layout table for eligibility information
Ages Eligible for Study:   60 Years to 85 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Primary care clinic
Criteria

Inclusion Criteria:

  • caucasian
  • arthroplasty intervention program with hip prosthesis placement
  • signature and acceptance of informed consent to collaborate in all the procedures necessary for the study

Exclusion Criteria:

  • heart failure stage III-IV
  • renal failure stage III-IV
  • actual cancer
  • past neurological disorders (including, but not limited to cerebral ischemia, cerebral haemorrhages, brain tumors, endocranial aneurysms)
  • neurodegenerative disorders (including, but not limited to Alzheimer's dementia, fronto-temporal dementia)
  • actual major psychopharmacological therapies
  • pregnancy certified by self-declaration
  • inability to adhere to the rehabilitation protocol or to carry out the controls
  • non-acceptance of informed consent
  • revision interventions
  • previously established and documented sleep disorders
  • shift or part-time worker
Contacts and Locations

Contacts
Layout table for location contacts
Contact: Matteo Briguglio 00393386087042 docmatteobriguglio@gmail.com
Contact: Elena Cittera elena.cittera@grupposandonato.it

Locations
Layout table for location information
Italy
IRCCS Istituto Ortopedico Galeazzi Recruiting
Milan, Italy
Contact: Matteo Briguglio         
Sponsors and Collaborators
Istituto Ortopedico Galeazzi
Investigators
Layout table for investigator information
Principal Investigator: Matteo Briguglio IRCCS Istituto Ortopedico Galeazzi
Tracking Information
First Submitted Date May 22, 2019
First Posted Date June 10, 2019
Last Update Posted Date August 30, 2019
Actual Study Start Date May 31, 2019
Estimated Primary Completion Date April 2021   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: June 7, 2019)
Change from baseline level of hemoglobin at 14 days after surgical operation [ Time Frame: Before the surgical operation, after 3 days, after 14 days. ]
One of the main decision-making factors that guide the clinician to discharge the patient is the hemoglobin level. The association between preoperative hemoglobin and hemoglobin at discharge was already observed in past orthopedic cohorts, with a loss of 3.3 g/dl being considered clinically relevant. Patients with a better nutritional status may have a reduced fall in hemoglobin after the surgical operation.
Original Primary Outcome Measures Same as current
Change History
Current Secondary Outcome Measures
 (submitted: June 7, 2019)
  • Change from baseline level of pre-albumin at 14 days after surgical operation [ Time Frame: Before the surgical operation, after 3 days, after 14 days. ]
    Pre-albumin (mg/dl)
  • Change from baseline level of total lymphocyte count at 14 days after surgical operation [ Time Frame: Before the surgical operation, after 3 days, after 14 days. ]
    Total lymphocyte count (cells/mm^3)
  • Change from baseline level of iron at 14 days after surgical operation [ Time Frame: Before the surgical operation, after 3 days, after 14 days. ]
    Iron (μg/dl)
  • Change from baseline level of vitamin D at 14 days after surgical operation [ Time Frame: Before the surgical operation, after 3 days, after 14 days. ]
    25[OH]D (ng/ml)
  • Change from baseline of weight 14 days after surgical operation [ Time Frame: Before the surgical operation, after 3 days, after 14 days. ]
    Weight (kg)
  • Change from baseline of calf circumference 14 days after surgical operation [ Time Frame: Before the surgical operation, after 3 days, after 14 days. ]
    Calf circumference (cm)
  • Change from baseline of % of fat mass at 14 days after surgical operation [ Time Frame: Before the surgical operation, after 3 days, after 14 days. ]
    Bioelectrical impedance analysis (% of fat mass and % of lean mass)
  • Change from baseline of hand-grip strength at 14 days after surgical operation [ Time Frame: Before the surgical operation, after 3 days, after 14 days. ]
    Hand-grip strength (kg). For this test, the higher values, the better is.
  • Change from baseline of FIM test at 14 days after surgical operation [ Time Frame: Before the surgical operation, after 3 days, after 14 days. ]
    Functional Independence Measure (FIM) (18-126 point scale). For this test, the higher values, the better is.
  • Change from baseline of 10 meter walking test at 14 days after surgical operation [ Time Frame: Before the surgical operation, after 3 days, after 14 days. ]
    10 meter walking test (m/s). For this test, the higher values, the better is.
  • Change from baseline of POMA at 14 days after surgical operation [ Time Frame: Before the surgical operation, after 3 days, after 14 days. ]
    Performance Oriented Mobility Assessment (POMA) (0-32 point scale). For this test, the higher values, the better is.
Original Secondary Outcome Measures Same as current
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Prognostic Potential of Preoperative Nutritional Status and Postoperative Change in Patients Undergoing Hip Arthroplasty
Official Title Prognostic Potential of the Preoperative Nutritional Status and Its Postoperative Variation in Patients Undergoing Hip Arthroplasty
Brief Summary Data literature lacks of evidence concerning the variation of the nutritional status in patients undergoing hip surgery, thus preventing an effective application a nutritional support program. It is therefore necessary to start identifying the clinical steps (pre-operative and post-operative) that may be defined as critical control points for malnutrition. The observation should foresee the identification of nutritional status indicators, such as weight, hemoglobin, albumin, food intake, and others that might affect a proper recovery. This study aims to investigate the prognostic nutritional factors that might influence clinical outcomes, and their variation in relation to hospitalization and rehabilitation periods.
Detailed Description Data literature lacks of evidence concerning the variation of the nutritional status in patients undergoing hip surgery, thus preventing an effective application a nutritional support program. It is therefore necessary to start identifying the clinical steps (pre-operative and post-operative) that may be defined as critical control points for malnutrition. Patients undergoing hip surgery would be enrolled before the surgical operation and would be evaluated three times: preoperative, postoperative, and after discharge. The observation should foresee the identification of nutritional status indicators, such as weight, hemoglobin, albumin, food intake, and others that might affect a proper recovery. This study aims to investigate the prognostic nutritional factors that might influence clinical outcomes, and their variation in relation to hospitalization and rehabilitation periods.
Study Type Observational
Study Design Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Probability Sample
Study Population Primary care clinic
Condition
  • Hip Arthropathy
  • Malnutrition; Anemia
  • Frail Elderly Syndrome
Intervention Not Provided
Study Groups/Cohorts Not Provided
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Recruiting
Estimated Enrollment
 (submitted: June 7, 2019)
60
Original Estimated Enrollment Same as current
Estimated Study Completion Date April 2022
Estimated Primary Completion Date April 2021   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • caucasian
  • arthroplasty intervention program with hip prosthesis placement
  • signature and acceptance of informed consent to collaborate in all the procedures necessary for the study

Exclusion Criteria:

  • heart failure stage III-IV
  • renal failure stage III-IV
  • actual cancer
  • past neurological disorders (including, but not limited to cerebral ischemia, cerebral haemorrhages, brain tumors, endocranial aneurysms)
  • neurodegenerative disorders (including, but not limited to Alzheimer's dementia, fronto-temporal dementia)
  • actual major psychopharmacological therapies
  • pregnancy certified by self-declaration
  • inability to adhere to the rehabilitation protocol or to carry out the controls
  • non-acceptance of informed consent
  • revision interventions
  • previously established and documented sleep disorders
  • shift or part-time worker
Sex/Gender
Sexes Eligible for Study: All
Ages 60 Years to 85 Years   (Adult, Older Adult)
Accepts Healthy Volunteers Yes
Contacts
Contact: Matteo Briguglio 00393386087042 docmatteobriguglio@gmail.com
Contact: Elena Cittera elena.cittera@grupposandonato.it
Listed Location Countries Italy
Removed Location Countries  
 
Administrative Information
NCT Number NCT03981354
Other Study ID Numbers NUTRIANCA
Has Data Monitoring Committee Not Provided
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement
Plan to Share IPD: Undecided
Responsible Party Istituto Ortopedico Galeazzi
Study Sponsor Istituto Ortopedico Galeazzi
Collaborators Not Provided
Investigators
Principal Investigator: Matteo Briguglio IRCCS Istituto Ortopedico Galeazzi
PRS Account Istituto Ortopedico Galeazzi
Verification Date August 2019